Abstract
The N-acetyl-S-(1-carbamoyl-2-hydroxy-ethyl)-l-cysteine (iso-GAMA) could be identified as a further human metabolite of acrylamide. In this study, we report the excretion of d3-iso-GAMA in human urine after single oral administration of deuterium labelled acrylamide (d3-AA). One healthy male volunteer ingested a dose of about 1 mg d3-AA which is equivalent to a dose of 13 μg/kg bodyweight. Over a period of 46 h the urine was collected and the d3-iso-GAMA levels analysed by LC-ESI-MS/MS. The excretion of iso-GAMA begins five hours after application. It rises to a maximum concentration (c max) of 43 μg/l which was quantified in the urine excreted after 22 h (t max). The excretion pattern is parallel to that of the major oxidative metabolite N-acetyl-S-(2-carbamoyl-2-hydroxy-ethyl)-l-cysteine (GAMA). Total recovery of iso-GAMA was about 1% of the applied dose. Together with N-acetyl-S-(2-carbamoylethyl)-l-cysteine (AAMA) and GAMA, 57% of the applied dose is eliminated as mercapturic acids. The elimination kinetics of the three mercapturic acids of AA are compared. We show that dietary doses of acrylamide (AA) cause an overload of detoxification via AAMA and lead to the formation of carcinogenic glycidamide (GA) in the human body.
References
Boettcher MI, Angerer J (2005) Determination of the major mercapturic acids of acrylamide and glycidamide in human urine by LC-ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 824:283–294
Boettcher MI, Schettgen T, Kutting B, Pischetsrieder M, Angerer J (2005) Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. Mutat Res 580:167–176
Boettcher MI, Bolt HM, Angerer J (2006a) Acrylamide exposure via the diet: influence of fasting on urinary mercapturic acid metabolite excretion in humans. Arch Toxicol 80:817–819
Boettcher MI, Bolt HM, Drexler H, Angerer J (2006b) Excretion of mercapturic acids of acrylamide and glycidamide in human urine after single oral administration of deuterium-labelled acrylamide. Arch Toxicol 80:55–61
DFG (Deutsche Forschungsgemeinschaft) (2002) Maximale Arbeitsplatzkonzentrationen und biologische Arbeitsstoff Toleranzwerte. Mitteilung XXXVIII der Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Wiley-VCH, Weinheim
EPA US (Office of Toxic Substances; U.S. Environmental Protection Agency) (1994) Chemical summary for acrylamide, Washington DC
EU European Commission (2001) Opinion on the results of the risk assessment of: acrylamide. Scientific Committee on Food, Brussels
Fennell TR et al (2005) Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85:447–459
Fuhr U et al (2006) Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 15:266–271
Hartmann EC, Boettcher MI, Schettgen T, Fromme H, Drexler H, Angerer J (2008) Hemoglobin adducts and mercapturic acid excretion of acrylamide and glycidamide in one study population. J Agric Food Chem 56:6061–6068
IARC (International Agency for Research on Cancer) (1994) Acrylamide. Summaries and evaluations, vol 60, p 389
Sumner SC, MacNeela JP, Fennell TR (1992) Characterization and quantitation of urinary metabolites of [1, 2, 3–13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem Res Toxicol 5:81–89
Tareke E, Rydberg P, Karlsson P, Eriksson S, Tornqvist M (2002) Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50:4998–5006
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hartmann, E.C., Boettcher, M.I., Bolt, H.M. et al. N-Acetyl-S-(1-carbamoyl-2-hydroxy-ethyl)-l-cysteine (iso-GAMA) a further product of human metabolism of acrylamide: comparison with the simultaneously excreted other mercaptuic acids. Arch Toxicol 83, 731–734 (2009). https://doi.org/10.1007/s00204-008-0369-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-008-0369-8